Zhejiang Hengkang Pharmaceutical

Zhejiang Hengkang Pharmaceutical Co. Ltd. was established in 2004. Hengkang is specialized in active pharmaceutical ingredients development, GMP manufacturing and marketing and it provides the most innovative intermediates and APIs to world-wide customers. Small molecular business sector has international standard facilities for API manufacturing and a professional team with cutting-edge technology, and provides the most innovative intermediates and active pharmaceutical ingredients to world-wide customers. Hengkang obtained: Drug Production License in 2006, GMP Certificate for Amiodarone Hydrochloride in October 2008, the Japanese Accreditation Certificate of Foreign manufacturer in December 2008, and the accreditation for High and New Technology Enterprise in 2017. Hengkang has self-support import-export authorization with business addressed to the global market. After years of professional team’s effort, we have established long-term stable trade partnership with about 70 overseas countries and hundreds of domestic manufacturers. In the next three years, the company aims to develop a pharmaceutical whole industrial group which covers new drugs early stage research and development to the large-scale commercial manufacturing and global marketing. Nucleic Acid business sector is led by PhD team with rich pharmaceutical industry background, focusing on the independent research and development of key raw materials and excipients of mRNA drugs and oligos, such as Cap Analog and intermediate, Nucleotide, modified Nucleotide, Enzyme, Cationic acid(Ionizable Lipid), phosphoramidite, and commercial production base with GMP system. Dedicated to become the best partner of innovative nucleic acid drug field. Can provide nucleotides and modified nucleotides, the product quality has reached the international level, and the cost is controllable, and the batch-to-batch quality is stable; Can provide capping materials for mRNA synthesis to achieve efficient and economical co